Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02953886 · ClinicalTrials.gov registry record · Phase 4

The Effect of Silver Diamine Fluoride (SDF) on Bacteria Involved in Root or Cervical Carious Lesions

A Phase 4 study of Caries, sponsored by Heba Mitwalli.

Completed
Registry status
Phase 4
Development phase
21
Enrollment target
1
Study location

NCT02953886: Completed Phase 4 study of Caries, sponsored by Heba Mitwalli.

NCT02953886 is a Phase 4 study of Caries that has completed, run by Heba Mitwalli. The registered enrollment target is 21 participants, below the 57-participant average among 7 other Caries trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02953886, a Phase 4 study of Caries, has completed, sponsored by Heba Mitwalli.

COMPLETED
Registry status
Phase 4
Development phase
21 participants
Enrollment target
1
Study location

Study Summary

The study will compare bacteria levels in cavities before and after silver diamine fluoride (SDF) treatment.

Primary Outcome

Using human oral microbiome identification using next-generation sequencing (HOMINGS), change in the total bacterial composition of all subjects was measured by the difference of the number of bacteria count from baseline to one month after SDF application.

Conditions Studied

Interventions

  • DEVICE Silver Diamine Fluoride (SDF)

Study Locations (1)

Michigan

  • University of Michigan School of Dentistry - Ann Arbor

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2016-11
Est. Completion 2017-04-20
Phase Phase 4
Heba Mitwalli

1 total trials

What the finished NCT02953886 record still lists

NCT02953886 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 57-participant average among 7 other Caries trials with a reported enrollment target (63% lower).

The record links to 1 condition, with Caries appearing as the primary indexed condition, and to 1 intervention - of which Silver Diamine Fluoride (SDF) is the first listed.

NCT02953886 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT02953886 about?

NCT02953886 is a clinical study titled "The Effect of Silver Diamine Fluoride (SDF) on Bacteria Involved in Root or Cervical Carious Lesions". The study will compare bacteria levels in cavities before and after silver diamine fluoride (SDF) treatment.

What is the current status of trial NCT02953886?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 21 participants. The study started on 2016-11. Estimated completion is 2017-04-20.

What conditions does trial NCT02953886 study?

This clinical trial studies the following conditions: Caries.

What interventions are being tested in trial NCT02953886?

The interventions under investigation include: Silver Diamine Fluoride (SDF) (DEVICE).

Who is sponsoring clinical trial NCT02953886?

This trial is sponsored by Heba Mitwalli, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02953886 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Caries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02447874 · 21 participants · Phase 1

    Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease

  • NCT03826992 · 21 participants · Phase 1

    Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia

  • NCT04107077 · 21 participants · Phase 2

    Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer

  • NCT04158635 · 21 participants · Phase 1

    Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02953886, the US trial registry maintained by the National Library of Medicine. NCT02953886 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.